Results 51 to 60 of about 1,443 (145)

Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development

open access: yesSmall, Volume 22, Issue 16, 17 March 2026.
Extracellular vesicles (EVs) hold promise for chronic obstructive pulmonary disease (COPD) treatment but face challenges with storage and delivery. This study demonstrates the stabilization of lung fibroblast‐derived EVs using inulin, enabling freeze‐drying and spray‐drying.
Eva M. Jansen   +7 more
wiley   +1 more source

Effects of environmental factors on genetic diversity in the endangered Notopterygium incisum from the southeastern Qinghai–Tibetan Plateau

open access: yesPlant Species Biology, Volume 41, Issue 2, March 2026.
This study focuses on 38 populations of Notopterygium incisum from its main distribution areas (Sichuan Province, Gansu Province, and Qinghai Province), conducting molecular genetic diversity analysis and investigating the correlations between genetic variation and climatic variables, geographical distribution, and elevation gradients.
Jinqiu Liao   +7 more
wiley   +1 more source

Evaluating the Pharmaceutical Sector Through Pharmacopoeial Standards: A Review [PDF]

open access: yes, 2023
For the pharmaceutical tablet to be considered a standard drug approval, it must fulfillcertain requirements. Various standard factors, including identification, strength, quality,purity, and stability, are used by pharmaceutical companies to test ...
Ch. Vineela   +3 more
core   +1 more source

Making the Old New Again Through the Process of Recombinant Innovation

open access: yesJournal of Product Innovation Management, Volume 43, Issue 2, Page 290-312, March 2026.
ABSTRACT Academic Summary Recombinant innovation—the process through which atypical and unexpected combinations of knowledge generate novel outcomes—is a critical driver of organizational distinctiveness and market transformation. While prior research has focused on firm‐ and industry‐level mechanisms, less attention has been given to multilevel ...
Vittoria Magrelli   +4 more
wiley   +1 more source

Ionic liquids: A pharmaceutical perspective [PDF]

open access: yes, 2014
In the last decades, ionic liquids (ILs) progressed from chemical curiosities to interesting biological compounds apprehending the attention of researchers of distinct areas, from chemistry to pharmacology.
M. Lúcia M.F.S. Saraiva
core  

Repurposing Drugs as Bacteroides fragilis BFT‐3 Inhibitors in the Animal Infection Model Galleria mellonella

open access: yesAnnals of the New York Academy of Sciences, Volume 1557, Issue 1, March 2026.
This work establishes a newly developed Galleria mellonella infection model as a powerful, ethical platform for studying Bacteroides fragilis pathogenesis and therapy. Leveraging this model, the study identifies MOA4 as a potent BFT‐3 inhibitor that improves host survival, increases bacterial clearance, and synergizes with antibiotics without toxicity.
Ana Jiménez‐Alesanco   +6 more
wiley   +1 more source

Artemisinin‐Based Combination Therapies in East Africa: A Systematic Review of Quality, Clinical Efficacy, and Regulatory Progress Towards Sustainable Malaria Control

open access: yesTropical Medicine &International Health, Volume 31, Issue 3, Page 254-273, March 2026.
ABSTRACT Background Malaria is a major public health issue in East Africa, leading to widespread illness and fatalities, especially among vulnerable populations such as children under 5 years of age and pregnant women. Artemisinin‐based combination therapies (ACTs) are the primary treatment modality; however, their efficacy is undermined by the ...
Yesuneh Tefera Mekasha   +5 more
wiley   +1 more source

Special Libraries, September 1966 [PDF]

open access: yes, 1966
Volume 57, Issue 7https://scholarworks.sjsu.edu/sla_sl_1966/1006/thumbnail ...
Special Libraries Association
core   +1 more source

Safety of 3′‐sialyllactose (3′‐SL) sodium salt produced with a derivative strain (Escherichia coli K‐12 MG1655 INB‐3SL_01) of E. coli K‐12 MG1655 (ATCC 700926) as a novel food pursuant to Regulation (EU) 2015/2283

open access: yesEFSA Journal, Volume 24, Issue 3, March 2026.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on 3′‐sialyllactose (3′‐SL) sodium salt as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is mainly composed of the human‐identical milk oligosaccharide (HiMO) 3′‐SL (sodium salt),
EFSA Panel on Nutrition   +23 more
wiley   +1 more source

Safety and efficacy of a feed additive consisting of narasin and diclazuril (Interban®) for chickens for fattening and chickens reared for laying (Elanco GmbH)

open access: yesEFSA Journal, Volume 24, Issue 3, March 2026.
Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of the coccidiostat consisting of narasin and diclazuril (Interban®) for chickens for fattening and chickens reared for laying. The FEEDAP Panel concludes that the use of Streptomyces sp. NRRL B‐67771 in the production of
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)   +33 more
wiley   +1 more source

Home - About - Disclaimer - Privacy